United Therapeutics (UTHR) Notes Payables (2009 - 2016)

United Therapeutics (UTHR) has 8 years of Notes Payables data on file, last reported at $900000.0 in Q2 2016.

• For the quarter ending Q2 2016, Notes Payables fell 97.21% year-over-year to $900000.0; the trailing twelve-month figure through Jun 2016 stood at $900000.0 (down 97.21% YoY), and the FY2015 full-year result was $5.4 million, down 95.73% from the prior year.
• Notes Payables fell to $900000.0 in Q2 2016, from $5.4 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $221.7 million in Q2 2014 to a low of $900000.0 in Q2 2016.
• A 5-year average of $104.5 million and a median of $90.9 million in 2014 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables jumped 16619.21% in 2013 and sank 97.21% in 2016, its largest moves.
• Tracing UTHR's Notes Payables over 5 years: stood at $1.3 million in 2012, then jumped by 16619.21% to $215.8 million in 2013, then sank by 41.43% to $126.4 million in 2014, then sank by 95.73% to $5.4 million in 2015, then sank by 83.33% to $900000.0 in 2016.
• Business Quant data shows UTHR's Notes Payables at $900000.0 in Q2 2016, $5.4 million in Q1 2016, and $5.4 million in Q4 2015.